You are here

Blenrep

GSK plots Blenrep's plot back to market with EU filing

BioSpace

Mon, 07/22/24 - 11:33 am

Multiple Myeloma

From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep

Fierce Pharma

Mon, 06/17/24 - 10:32 pm

Multiple Myeloma

GSK, attempting to stage Blenrep comeback, bids adieu to combo studies with SpringWorks' Ogsiveo

Fierce Pharma

Mon, 06/10/24 - 11:23 am

SpringWorks Therapeutics

ASCO: GSK builds case for return of multiple myeloma drug Blenrep

BioPharma Dive

Sun, 06/2/24 - 02:45 pm

mutliple myeloma

GSK Advances Blenrep’s Potential Comeback with Second Phase III Win

BioSpace

Thu, 03/7/24 - 05:32 pm

antibody-drug conjugate

GSK reports positive news on trio of high-profile products

Medical Marketing and Media

Wed, 02/7/24 - 09:13 pm

GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma

BioSpace

Tue, 02/6/24 - 09:25 am

Multiple Myeloma

clinical trials

GSK cancer drug Blenrep gets surprise trial win

BioPharma Dive

Tue, 11/28/23 - 10:19 am

clinical trials

Multiple Myeloma

JPM23: Is GSK's 15-day accelerated approval withdrawal the new normal? Hear FDA Commissioner Robert Califf's response

Fierce Pharma

Thu, 01/12/23 - 09:20 pm

GSK’s “crown jewels” already look tarnished

EP Vantage

Wed, 11/23/22 - 07:27 am

GSK to pull blood cancer drug from US market after study failure

BioPharma Dive

Tue, 11/22/22 - 11:08 am

clinical trials

Multiple Myeloma

Time for GSK to stop dreaming about Blenrep

EP Vantage

Mon, 11/7/22 - 10:53 am

clinical trials

Multiple Myeloma

GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep

Fierce Biotech

Mon, 08/8/22 - 11:45 pm

antibody-drug conjugate